267 related articles for article (PubMed ID: 37368402)
1. Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis.
Liu M; Gao Y; Yuan Y; Yang K; Shen C; Wang J; Tian J
JAMA Netw Open; 2023 Jun; 6(6):e2320351. PubMed ID: 37368402
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis.
Wei D; Chen Y; Shen Y; Xie B; Song X
Front Immunol; 2023; 14():1152513. PubMed ID: 37138884
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of JAK inhibitors on effect and safety in alopecia areata: a systematic review and meta-analysis of 2018 patients.
Mao MQ; Ding YX; Jing J; Tang ZW; Miao YJ; Yang XS; Chen YH; Chen SZ; Wu XJ; Lu ZF
Front Immunol; 2023; 14():1195858. PubMed ID: 37334349
[TBL] [Abstract][Full Text] [Related]
6. Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review.
Egeberg A; Linsell L; Johansson E; Durand F; Yu G; Vañó-Galván S
Dermatol Ther (Heidelb); 2023 Dec; 13(12):2951-2991. PubMed ID: 37833617
[TBL] [Abstract][Full Text] [Related]
7. Comparative Efficacy and Safety of Janus Kinase Inhibitors Used in Alopecia Areata: A Systematic Review and Meta-analysis.
Barati Sedeh F; Michaelsdóttir TE; Henning MAS; Jemec GBE; Ibler KS
Acta Derm Venereol; 2023 Jan; 103():adv00855. PubMed ID: 36695751
[TBL] [Abstract][Full Text] [Related]
8. A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results.
King B; Guttman-Yassky E; Peeva E; Banerjee A; Sinclair R; Pavel AB; Zhu L; Cox LA; Craiglow B; Chen L; Banfield C; Page K; Zhang W; Vincent MS
J Am Acad Dermatol; 2021 Aug; 85(2):379-387. PubMed ID: 33757798
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of JAK inhibitors in the treatment of alopecia areata in children: a systematic review and meta-analysis.
Chen Y; Zhu H; Shen Y; Zhu Y; Sun J; Dai Y; Song X
J Dermatolog Treat; 2022 Dec; 33(8):3143-3149. PubMed ID: 36214579
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-6 blocking agents for treating COVID-19: a living systematic review.
Ghosn L; Chaimani A; Evrenoglou T; Davidson M; Graña C; Schmucker C; Bollig C; Henschke N; Sguassero Y; Nejstgaard CH; Menon S; Nguyen TV; Ferrand G; Kapp P; Riveros C; Ávila C; Devane D; Meerpohl JJ; Rada G; Hróbjartsson A; Grasselli G; Tovey D; Ravaud P; Boutron I
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013881. PubMed ID: 33734435
[TBL] [Abstract][Full Text] [Related]
11. Short-Term Cardiovascular Complications in Dermatology Patients Receiving JAK-STAT Inhibitors: A Meta-Analysis of Randomized Clinical Trials.
Ireland PA; Jansson N; Spencer SKR; Braden J; Sebaratnam D
JAMA Dermatol; 2024 Mar; 160(3):281-289. PubMed ID: 38294793
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2).
Kwon O; Senna MM; Sinclair R; Ito T; Dutronc Y; Lin CY; Yu G; Chiasserini C; McCollam J; Wu WS; King B
Am J Clin Dermatol; 2023 May; 24(3):443-451. PubMed ID: 36855020
[TBL] [Abstract][Full Text] [Related]
13. JAK inhibitors for alopecia areata: a systematic review and meta-analysis.
Phan K; Sebaratnam DF
J Eur Acad Dermatol Venereol; 2019 May; 33(5):850-856. PubMed ID: 30762909
[TBL] [Abstract][Full Text] [Related]
14. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
15. Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study.
Almutairi N; Nour TM; Hussain NH
Dermatology; 2019; 235(2):130-136. PubMed ID: 30566941
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment for familial amyloid polyneuropathy.
Magrinelli F; Fabrizi GM; Santoro L; Manganelli F; Zanette G; Cavallaro T; Tamburin S
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012395. PubMed ID: 32311072
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies.
Yan D; Fan H; Chen M; Xia L; Wang S; Dong W; Wang Q; Niu S; Rao H; Chen L; Nie X; Fang Y
Front Pharmacol; 2022; 13():950450. PubMed ID: 36091777
[No Abstract] [Full Text] [Related]
18. Non-steroidal anti-inflammatory drugs for acute low back pain.
van der Gaag WH; Roelofs PD; Enthoven WT; van Tulder MW; Koes BW
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013581. PubMed ID: 32297973
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture and related interventions for the treatment of symptoms associated with carpal tunnel syndrome.
Choi GH; Wieland LS; Lee H; Sim H; Lee MS; Shin BC
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011215. PubMed ID: 30521680
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Comparative Efficacy and Safety of Surgical Approaches for Total Hip Arthroplasty: A Systematic Review and Network Meta-analysis.
Yan L; Ge L; Dong S; Saluja K; Li D; Reddy KS; Wang Q; Yao L; Li JJ; Roza da Costa B; Xing D; Wang B
JAMA Netw Open; 2023 Jan; 6(1):e2253942. PubMed ID: 36719679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]